Cargando…
Effects of synthetic peptide RP557 and its origin, LL-37, on carbapenem-resistant Pseudomonas aeruginosa
Pseudomonas aeruginosa is a common bacterium in nosocomial infection. The biofilm-forming ability and antimicrobial resistance make P. aeruginosa biofilm infection refractory to patients requiring hospitalization, especially patients in the intensive care unit. Therefore, many alternative compounds...
Autores principales: | Song, Yun-Qi, Kyung, Su Min, Kim, Suji, Kim, Gun, Lee, So Yeong, Yoo, Han Sang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581083/ https://www.ncbi.nlm.nih.gov/pubmed/37555659 http://dx.doi.org/10.1128/spectrum.00430-23 |
Ejemplares similares
-
Susceptibility of Pseudomonas aeruginosa Biofilm to Alpha-Helical Peptides: D-enantiomer of LL-37
por: Dean, Scott N., et al.
Publicado: (2011) -
The effects of LL-37 on virulence factors related to the quorum sensing system of Pseudomonas aeruginosa
por: Xiao, Qian, et al.
Publicado: (2022) -
Human Host Defense Peptide LL-37 Stimulates Virulence Factor Production and Adaptive Resistance in Pseudomonas aeruginosa
por: Strempel, Nikola, et al.
Publicado: (2013) -
Evaluation of the Antimicrobial Peptide, RP557, for the Broad-Spectrum Treatment of Wound Pathogens and Biofilm
por: Woodburn, Kathryn Wynne, et al.
Publicado: (2019) -
Synergy between Human Peptide LL-37 and Polymyxin B against Planktonic and Biofilm Cells of Escherichia coli and Pseudomonas aeruginosa
por: Ridyard, Kylen E., et al.
Publicado: (2023)